Trial intelligence / Profile preview

MSCs and Everolimus for Tacrolimus Withdrawal in Kidney Transplant

NCT02057965Phase 2Unknown

Sponsor
Leiden University Medical Center
Start
Mar 2014
Primary completion
Jan 2020
Countries
1
01

Overview

A Phase 2 trial of Provacel in renal transplant rejection (RTR), fibrosis, sponsored by Leiden University Medical Center. Status: unknown.

02

Drugs

Provacel
03

Conditions

renal transplant rejection (RTR)fibrosis

Beyond the preview

Go deeper on NCT02057965.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02057965.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call